Leman Yel
10PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 14, 2025
Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases.Niraj C Patel, Jolan E Walter, Richard L Wasserman
|Sep 17, 2024
fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.Peter Čižnár, Marion Roderick, Helen Schneiderova
|Jul 09, 2024
Dose-exposure-efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy.Zhaoyang Li, Stefan Roepcke, Ryan Franke
|Jun 19, 2024
Tolerability and Safety of Large-Volume Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% Administered with or without Dose Ramp-Up: A Phase 1 Study in Healthy Participants.Zhaoyang Li, Andras Nagy, Dirk Lindner
|Jun 18, 2024
Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study.Pauline M Ellerbroek, Leif G Hanitsch, Torsten Witte
|Mar 21, 2024
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study.Hirokazu Kanegane, Akifumi Endo, Satoshi Okada
Pageof 2
Frequent Collaborators
6 joint publications
Zhaoyang Li
2 joint publications
Richard L Wasserman
2 joint publications
Andras Nagy
2 joint publications
Kimberly Duff
1 joint publications
Sudhir Gupta
1 joint publications
Mark Stein
1 joint publications
Christopher J Rabbat
1 joint publications
Werner Engl
1 joint publications
Heinz Leibl
1 joint publications
Martin Hrubiško
